CytomX Therapeutics Inc (NASDAQ:CTMX) shares, rose in value on Thursday, July 10, with the stock price up by 4.42% to the previous day’s close as strong demand from buyers drove the stock to $2.6.
Actively observing the price movement in the last trading, the stock closed the session at $2.49, falling within a range of $2.44 and $2.79. The value of beta (5-year monthly) was 2.12 whereas the PE ratio was 5.24 over 12-month period. Referring to stock’s 52-week performance, its high was $3.10, and the low was $0.40. On the whole, CTMX has fluctuated by -1.33% over the past month.
With the market capitalization of CytomX Therapeutics Inc currently standing at about $409.62 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-12.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 98.75M, with a low estimate of 4M and a high estimate of 30M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 19.1M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CTMX’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of CTMX currently trading nearly 7.50% and 23.10% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 59.39, while the 7-day volatility ratio is showing 6.98% which for the 30-day chart, stands at 9.39%. Furthermore, CytomX Therapeutics Inc (CTMX)’s beta value is 2.14.
A comparison of CytomX Therapeutics Inc (CTMX) with its peers suggests the former has fared considerably weaker in the market. CTMX showed an intraday change of 4.42% in last session, and over the past year, it grew by 152.43%%.
Data on historical trading for CytomX Therapeutics Inc (NASDAQ:CTMX) indicates that the trading volumes over the past 10 days have averaged 2.03 and over the past 3 months, they’ve averaged 5.17 million. According to company’s latest data on outstanding shares, there are 157.54 million shares outstanding.
Nearly 33.99% of CytomX Therapeutics Inc’s shares belong to company insiders and institutional investors own 35.39% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 20.79 million shares as on 2025-06-13, resulting in a short ratio of 4.32. According to the data, the short interest in CytomX Therapeutics Inc (CTMX) stood at 1371.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 17.73 million. The stock has risen by 100.00% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CTMX stock heading into the next quarter.
